Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 6,970.00
-240.00 (-3.33%)
Aug 3, 2026, 3:30 PM KST
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 107 billion as of August 3, 2026. Its market cap has decreased by -18.38% in one year.
Market Cap
107.00B
Enterprise Value
348.02B
Revenue
625.97B
Ranking
n/a
PE Ratio
7.97
Stock Price
6,970.00
ChartMarket Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 107.00B, an increase of 306.90%. That is a compound annual growth rate of 4.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 107.00B | -13.31% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 148.35B |
| Ilsung Is | 140.08B |
| Jeil Pharmaceutical Co.,Ltd | 137.41B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| Dongwha Pharm.Co.,Ltd | 129.72B |
| AptaBio Therapeutics | 129.09B |
| Kyongbo Pharmaceutical | 121.69B |
| SAMSUNG PHARM. Co., LTD. | 116.62B |